Glutamate release in human cerebral cortex and its modulation by 5-hydroxtryptamine acting at h 5-HT(1D) receptors

Guido Maura, Manuela Marcoli, Massimo Tortarolo, Gian Carlo Andrioli, Maurizio Raiteri

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

1. The release of glutamic acid and its modulation by 5-hydroxytryptamine (5-HT) in the human brain has been investigated in synaptosomal preparations from fresh neocortical samples obtained from patients undergoing neurosurgery to reach deeply sited tumours. 2. The Ca2+-dependant K+ (15 mM)-evoked overflow of glutamate was inhibited by 5-HT in a concentration-dependant manner (EC50 = 2.9 nM; maximal effect ≃ 50%). The inhibition caused by 5-HT was antagonized by the 5-HT1/5-HT2 receptor antagonist methiothepin. The 5-HT(1B)/5-HT(1D) receptor agonist sumatriptan mimicked 5-HT (EC50 = 6.4 nM; maximal effect ≃ 50%); the effect of sumatriptan was also methiothepin-sensitive. Selective 5-HT(1A) receptor antagonists could not prevent the inhibition of glutamate release by 5-HT. 3. The 5-HT(1B)/5-HT(1D) receptor ligand GR 127935 and the 5-HT(2C)/5-HT(1B)/5-HT(1D) receptor ligand metergoline were able to prevent the 5-HT effect; instead they inhibited glutamate release, their effects being abolished by methiothepin. Some 5-HT(1A) receptor antagonists also displayed intrinsic agonist activity. 4. The effect of sumatriptan was prevented by ketanserin, a drug known to display much higher affinity for recombinant h 5-HT(1D) than for h 5-HT(1B) receptors. 5. We propose that neocortical glutamatergic nerve terminals in human brain cortex posses release-inhibiting presynaptic heteroreceptors that appear to belong to the h 5-HT(1D) subtype.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalBritish Journal of Pharmacology
Volume123
Issue number1
DOIs
Publication statusPublished - 1998

Fingerprint

Serotonin Receptors
Cerebral Cortex
Glutamic Acid
Serotonin
Receptor, Serotonin, 5-HT1B
Methiothepin
Sumatriptan
Receptor, Serotonin, 5-HT1A
Metergoline
Ligands
Serotonin 5-HT2 Receptor Antagonists
Ketanserin
Brain
Neurosurgery

Keywords

  • 5-hydroxytryptamine-glutamate interaction
  • Glutamate release
  • h 5-HT(1D) receptor
  • Human cerebral cortex
  • Human native 5-hydroxytryptamine receptors

ASJC Scopus subject areas

  • Pharmacology

Cite this

Glutamate release in human cerebral cortex and its modulation by 5-hydroxtryptamine acting at h 5-HT(1D) receptors. / Maura, Guido; Marcoli, Manuela; Tortarolo, Massimo; Andrioli, Gian Carlo; Raiteri, Maurizio.

In: British Journal of Pharmacology, Vol. 123, No. 1, 1998, p. 45-50.

Research output: Contribution to journalArticle

Maura, Guido ; Marcoli, Manuela ; Tortarolo, Massimo ; Andrioli, Gian Carlo ; Raiteri, Maurizio. / Glutamate release in human cerebral cortex and its modulation by 5-hydroxtryptamine acting at h 5-HT(1D) receptors. In: British Journal of Pharmacology. 1998 ; Vol. 123, No. 1. pp. 45-50.
@article{ba6810d8409b46a2b188d7d4c69c88c2,
title = "Glutamate release in human cerebral cortex and its modulation by 5-hydroxtryptamine acting at h 5-HT(1D) receptors",
abstract = "1. The release of glutamic acid and its modulation by 5-hydroxytryptamine (5-HT) in the human brain has been investigated in synaptosomal preparations from fresh neocortical samples obtained from patients undergoing neurosurgery to reach deeply sited tumours. 2. The Ca2+-dependant K+ (15 mM)-evoked overflow of glutamate was inhibited by 5-HT in a concentration-dependant manner (EC50 = 2.9 nM; maximal effect ≃ 50{\%}). The inhibition caused by 5-HT was antagonized by the 5-HT1/5-HT2 receptor antagonist methiothepin. The 5-HT(1B)/5-HT(1D) receptor agonist sumatriptan mimicked 5-HT (EC50 = 6.4 nM; maximal effect ≃ 50{\%}); the effect of sumatriptan was also methiothepin-sensitive. Selective 5-HT(1A) receptor antagonists could not prevent the inhibition of glutamate release by 5-HT. 3. The 5-HT(1B)/5-HT(1D) receptor ligand GR 127935 and the 5-HT(2C)/5-HT(1B)/5-HT(1D) receptor ligand metergoline were able to prevent the 5-HT effect; instead they inhibited glutamate release, their effects being abolished by methiothepin. Some 5-HT(1A) receptor antagonists also displayed intrinsic agonist activity. 4. The effect of sumatriptan was prevented by ketanserin, a drug known to display much higher affinity for recombinant h 5-HT(1D) than for h 5-HT(1B) receptors. 5. We propose that neocortical glutamatergic nerve terminals in human brain cortex posses release-inhibiting presynaptic heteroreceptors that appear to belong to the h 5-HT(1D) subtype.",
keywords = "5-hydroxytryptamine-glutamate interaction, Glutamate release, h 5-HT(1D) receptor, Human cerebral cortex, Human native 5-hydroxytryptamine receptors",
author = "Guido Maura and Manuela Marcoli and Massimo Tortarolo and Andrioli, {Gian Carlo} and Maurizio Raiteri",
year = "1998",
doi = "10.1038/sj.bjp.0701581",
language = "English",
volume = "123",
pages = "45--50",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Glutamate release in human cerebral cortex and its modulation by 5-hydroxtryptamine acting at h 5-HT(1D) receptors

AU - Maura, Guido

AU - Marcoli, Manuela

AU - Tortarolo, Massimo

AU - Andrioli, Gian Carlo

AU - Raiteri, Maurizio

PY - 1998

Y1 - 1998

N2 - 1. The release of glutamic acid and its modulation by 5-hydroxytryptamine (5-HT) in the human brain has been investigated in synaptosomal preparations from fresh neocortical samples obtained from patients undergoing neurosurgery to reach deeply sited tumours. 2. The Ca2+-dependant K+ (15 mM)-evoked overflow of glutamate was inhibited by 5-HT in a concentration-dependant manner (EC50 = 2.9 nM; maximal effect ≃ 50%). The inhibition caused by 5-HT was antagonized by the 5-HT1/5-HT2 receptor antagonist methiothepin. The 5-HT(1B)/5-HT(1D) receptor agonist sumatriptan mimicked 5-HT (EC50 = 6.4 nM; maximal effect ≃ 50%); the effect of sumatriptan was also methiothepin-sensitive. Selective 5-HT(1A) receptor antagonists could not prevent the inhibition of glutamate release by 5-HT. 3. The 5-HT(1B)/5-HT(1D) receptor ligand GR 127935 and the 5-HT(2C)/5-HT(1B)/5-HT(1D) receptor ligand metergoline were able to prevent the 5-HT effect; instead they inhibited glutamate release, their effects being abolished by methiothepin. Some 5-HT(1A) receptor antagonists also displayed intrinsic agonist activity. 4. The effect of sumatriptan was prevented by ketanserin, a drug known to display much higher affinity for recombinant h 5-HT(1D) than for h 5-HT(1B) receptors. 5. We propose that neocortical glutamatergic nerve terminals in human brain cortex posses release-inhibiting presynaptic heteroreceptors that appear to belong to the h 5-HT(1D) subtype.

AB - 1. The release of glutamic acid and its modulation by 5-hydroxytryptamine (5-HT) in the human brain has been investigated in synaptosomal preparations from fresh neocortical samples obtained from patients undergoing neurosurgery to reach deeply sited tumours. 2. The Ca2+-dependant K+ (15 mM)-evoked overflow of glutamate was inhibited by 5-HT in a concentration-dependant manner (EC50 = 2.9 nM; maximal effect ≃ 50%). The inhibition caused by 5-HT was antagonized by the 5-HT1/5-HT2 receptor antagonist methiothepin. The 5-HT(1B)/5-HT(1D) receptor agonist sumatriptan mimicked 5-HT (EC50 = 6.4 nM; maximal effect ≃ 50%); the effect of sumatriptan was also methiothepin-sensitive. Selective 5-HT(1A) receptor antagonists could not prevent the inhibition of glutamate release by 5-HT. 3. The 5-HT(1B)/5-HT(1D) receptor ligand GR 127935 and the 5-HT(2C)/5-HT(1B)/5-HT(1D) receptor ligand metergoline were able to prevent the 5-HT effect; instead they inhibited glutamate release, their effects being abolished by methiothepin. Some 5-HT(1A) receptor antagonists also displayed intrinsic agonist activity. 4. The effect of sumatriptan was prevented by ketanserin, a drug known to display much higher affinity for recombinant h 5-HT(1D) than for h 5-HT(1B) receptors. 5. We propose that neocortical glutamatergic nerve terminals in human brain cortex posses release-inhibiting presynaptic heteroreceptors that appear to belong to the h 5-HT(1D) subtype.

KW - 5-hydroxytryptamine-glutamate interaction

KW - Glutamate release

KW - h 5-HT(1D) receptor

KW - Human cerebral cortex

KW - Human native 5-hydroxytryptamine receptors

UR - http://www.scopus.com/inward/record.url?scp=0031984344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031984344&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0701581

DO - 10.1038/sj.bjp.0701581

M3 - Article

VL - 123

SP - 45

EP - 50

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -